drugset / Trial / NCT03462043
A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension
RandomizedCrossoverOpen-labelTreatment
Summary
This study will assess the relative bioavailability of s.c. infused ND0612 versus jejunally infused CLES in patients with advanced PD.
Timeline
- Start
- 2018-04-10
- Primary completion
- 2018-11-20
- Completion
- 2018-12-30
Outcome
Outcome not reported
Stopped: “Decision to change the study design”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbidopa | Unknown | — | Other |
| Subject | Levodopa | Unknown | — | Other |
| Subject | ND0612 | Unknown | — | Subcutaneous |